EAST RUTHERFORD, N.J.
May 13, 2013
/PRNewswire/ -- Cambrex Corporation (NYSE: CBM, "Cambrex") is pleased to announce that
, President and Chief Executive Officer, will make a presentation on the Company at the UBS Global Healthcare Conference on
May 20, 2013
1:00 p.m. EDT
The live audio webcast and slide presentation can be accessed from the Cambrex website at
in the Investors section under "Webcasts & Presentations", and a replay will be available for 90 days after the live event concludes.
Cambrex Corporation is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics. The Company offers Active Pharmaceutical Ingredients (APIs), advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis, controlled substances and formulation of finished dosage form products. For more information, please visit
SOURCE Cambrex Corporation